NEW YORK ─ Hologic said on Thursday that it has inked an agreement to acquire Mobidiag, a developer of molecular diagnostic tests and instrumentation, for approximately $795 million.
The deal includes a cash payment of approximately $714 million for Mobidiag’s equity, and net debt of approximately $81 million, Marlborough, Massachusetts-based Hologic said. It added it anticipates financing the deal with cash on hand and borrowing from an existing line of credit.